raised $11.8 million in a Series B round of financing that included two new investors, the Redmile Group and Claremont Creek Ventures. Private investors from Genalyte’s Series A round also participated. The company says it plans to introduce its product this summer, initially addressing the autoimmunity research and testing markets.
—San Diego’s Tioga Pharmaceuticals, which is developing new drugs for treating gastrointestinal diseases, has raised $10 million from investors, according to a recent regulatory filing. On its website, Tioga says it was founded in 2005 by Forward Ventures and raised $24 million in Series A financing with New Leaf Venture Partners and BB Biotech Ventures.
—San Diego-based Adamis Pharmaceuticals has raised $3.3 million in equity, debt, and rights to securities, according to a recent regulatory filing. The company says it is combining specialty pharmaceuticals and biotechnology to develop innovative drugs in three areas, allergies, asthma, and respiratory diseases; cancer; and immunology and infectious diseases. The company was previously known as Cellegy Pharmaceuticals.
—San Diego-based Ocera Therapeutics has raised $1.5 million of a targeted $3 million in debt, rights, and securities, according to a recent regulatory filing. On its website, the company says CEO Laurent Fischer founded the company with Domain Associates partner Eckard Weber in 2005 to develop new drugs for treating liver and gastrointestinal diseases.
Author: Bruce V. Bigelow
In Memoriam: Our dear friend Bruce V. Bigelow passed away on June 29, 2018. He was the editor of Xconomy San Diego from 2008 to 2018. Read more about his life and work here.
Bruce Bigelow joined Xconomy from the business desk of the San Diego Union-Tribune. He was a member of the team of reporters who were awarded the 2006 Pulitzer Prize in National Reporting for uncovering bribes paid to San Diego Republican Rep. Randy “Duke” Cunningham in exchange for special legislation earmarks. He also shared a 2006 award for enterprise reporting from the Society of Business Editors and Writers for “In Harm’s Way,” an article about the extraordinary casualty rate among employees working in Iraq for San Diego’s Titan Corp. He has written extensively about the 2002 corporate accounting scandal at software goliath Peregrine Systems. He also was a Gerald Loeb Award finalist and National Headline Award winner for “The Toymaker,” a 14-part chronicle of a San Diego start-up company. He takes special satisfaction, though, that the series was included in the library for nonfiction narrative journalism at the Nieman Foundation for Journalism at Harvard University.
Bigelow graduated from U.C. Berkeley in 1977 with a degree in English Literature and from the Columbia University Graduate School of Journalism in 1979. Before joining the Union-Tribune in 1990, he worked for the Associated Press in Los Angeles and The Kansas City Times.
View all posts by Bruce V. Bigelow
